Walgreens Boots Alliance 将来の成長

Future 基準チェック /36

Walgreens Boots Alliance利益と収益がそれぞれ年間106.6%と1.5%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に12.8% 108.4%なると予測されています。

主要情報

106.6%

収益成長率

108.4%

EPS成長率

Consumer Retailing 収益成長	11.8%
収益成長率	1.5%
将来の株主資本利益率	12.8%
アナリストカバレッジ	Good
最終更新日	19 Nov 2024

今後の成長に関する最新情報

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Oct 17

Recent updates

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Nov 18

Walgreens Q4: 2 Signs Of A Dividend Trap

Oct 29

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Oct 23

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Oct 17

Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play

Aug 13

Walgreens: A Painful Turnaround Lesson

Aug 02

Walgreens: Here's What Comes Next

Jul 09

Walgreens: Yielding Over 8% Following The Earnings Drop

Jul 02

Walgreens: Beware The Value Trap Ahead Of Earnings

Jun 24

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

May 30

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

May 22

Walgreens: Hold Tight, Let It Turn Around First

May 06

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

May 05

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Apr 10

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Apr 08

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

Apr 04

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Mar 27

Walgreens' Strategic Pivot

Mar 21

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Mar 15

Walgreens: New CEO Looking To Right The Ship

Feb 13

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Jan 19

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Jan 17

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

Jan 10

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

Dec 24

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Oct 31

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Oct 02

業績と収益の成長予測

NasdaqGS:WBA - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
8/31/2027	153,872	321	1,178	2,366	8
8/31/2026	151,657	-62	382	1,600	15
8/31/2025	148,963	-570	-334	1,027	16
8/31/2024	147,658	-8,636	-363	1,018	N/A
5/31/2024	145,533	-5,811	-894	725	N/A
2/29/2024	144,597	-6,037	-1,766	101	N/A
11/30/2023	142,406	574	-529	1,484	N/A
8/31/2023	139,081	-3,080	141	2,258	N/A
5/31/2023	136,108	-3,315	-821	1,305	N/A
2/28/2023	133,291	-3,144	982	2,954	N/A
11/30/2022	132,184	-2,964	1,403	3,293	N/A
8/31/2022	132,703	4,337	2,165	3,899	N/A
5/31/2022	134,516	5,111	3,439	5,058	N/A
2/28/2022	135,948	5,926	3,626	5,183	N/A
11/30/2021	134,972	5,965	4,057	5,459	N/A
8/31/2021	132,509	1,994	4,176	5,555	N/A
5/31/2021	128,617	1,972	4,983	6,396	N/A
2/28/2021	124,952	-926	4,195	5,556	N/A
11/30/2020	123,509	-981	4,200	5,618	N/A
8/31/2020	121,982	179	4,110	5,484	N/A
5/31/2020	125,566	519	4,359	5,777	N/A
2/29/2020	129,792	3,339	5,269	6,883	N/A
11/30/2019	132,984	3,628	4,576	6,195	N/A
8/31/2019	120,074	3,816	3,892	5,594	N/A
5/31/2019	136,354	4,817	4,402	6,032	N/A
2/28/2019	136,097	5,133	4,756	6,250	N/A
11/30/2018	134,590	5,326	6,261	7,720	N/A
8/31/2018	131,537	5,024	6,896	8,263	N/A
5/31/2018	128,244	4,314	N/A	7,460	N/A
2/28/2018	124,028	4,134	N/A	7,077	N/A
11/30/2017	120,453	3,845	N/A	7,729	N/A
8/31/2017	118,214	4,078	N/A	7,255	N/A
5/31/2017	116,701	4,306	N/A	7,895	N/A
2/28/2017	116,081	4,247	N/A	8,144	N/A
11/30/2016	116,819	4,117	N/A	7,640	N/A
8/31/2016	117,351	4,173	N/A	7,847	N/A
5/31/2016	117,237	3,169	N/A	6,694	N/A
2/29/2016	116,534	3,368	N/A	6,412	N/A
11/30/2015	112,923	4,480	N/A	5,365	N/A
8/31/2015	103,444	4,220	N/A	5,664	N/A
5/31/2015	93,979	3,973	N/A	5,543	N/A
2/28/2015	84,585	3,385	N/A	4,993	N/A
11/30/2014	77,617	2,059	N/A	4,791	N/A
8/31/2014	76,392	1,932	N/A	3,893	N/A
5/31/2014	75,276	2,810	N/A	3,632	N/A
2/28/2014	74,188	2,720	N/A	3,739	N/A
11/30/2013	73,230	2,760	N/A	3,833	N/A

アナリストによる今後の成長予測

収入対貯蓄率: WBAは今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.6% ) よりも高い成長率であると考えられます。

収益対市場: WBA今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: WBA今後 3 年以内に収益を上げることが予想されます。

収益対市場: WBAの収益 ( 1.5% ) US市場 ( 8.9% ) よりも低い成長が予測されています。

高い収益成長: WBAの収益 ( 1.5% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: WBAの自己資本利益率は、3年後には低くなると予測されています ( 12.8 %)。

Walgreens Boots Alliance 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2025

Price target decreased by 7.5% to US$11.33

Price target decreased by 7.8% to US$11.46

Price target decreased by 8.7% to US$12.43

Price target decreased by 9.0% to US$20.21

Recent updates

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Walgreens Q4: 2 Signs Of A Dividend Trap

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on December 12, 2024

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Walgreens Boots Alliance, Inc. Expects to Close Approximately 1,200 Stores over the Next 3 Years with About 500 Targeted to Close in Fiscal 2025

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Walgreens: A Turnaround Stock To Avoid

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2025

Price target decreased by 7.5% to US$11.33

Price target decreased by 7.8% to US$11.46

Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer

Walgreens Stock: Cheap At 3x FWD P/E, But Still Not Worth Buying

Saxena White P.A. Files New Securities Fraud Class Action Lawsuit Against Walgreens Boots Alliance, Inc. and Certain of its Executives

Price target decreased by 8.7% to US$12.43

Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024

Is Walgreens Boots Alliance (NASDAQ:WBA) A Risky Investment?

Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses

Is Walgreens Ready To Rebound?

Walgreens Announces Executive Appointments

Upcoming dividend of US$0.25 per share

Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play

Walgreens: A Painful Turnaround Lesson

Gross Law Firm Announces Lawsuit Against Walgreens Boots Alliance, Inc

Third quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on September 12, 2024

Walgreens: Here's What Comes Next

Walgreens: Yielding Over 8% Following The Earnings Drop

Boots Chief Quits Reportedly After Walgreens' Sale Plan Stalls

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target decreased by 9.0% to US$20.21

Consensus EPS estimates fall by 41%

Walgreens: Beware The Value Trap Ahead Of Earnings

Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

Walgreens Announces Launch of Walgreens Brand Naloxone HCI Nasal Spray

Walgreens Reportedly Contacts Potential Buyers for £7 Billion Boots Drugstore Chain

Upcoming dividend of US$0.25 per share

Walgreens: Hold Tight, Let It Turn Around First

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Second quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

New major risk - Financial position

Consensus EPS estimates fall by 11%

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Walgreens' Strategic Pivot

Consensus EPS estimates increase by 11%

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Consensus EPS estimates fall by 14%

Walgreens: New CEO Looking To Right The Ship

Walgreens Boots Alliance, Inc. Announces Executive Changes

Upcoming dividend of US$0.25 per share at 4.4% yield

High number of new directors

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on March 12, 2024

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

The Shareholder Commons, Inc Files a Notice of Exempt Solicitation to Walgreens Boots Alliance, Inc